Can we address the "MM signals" theories for just one minute?

terminological inexactitude!!!!

DEAR NEWBIES and others......
I read the posts regarding signals at least once a week on ihub. That should be an honorary
TOS, in my very honest opinion.

58..59..60..
The End.

noted

he's a pasher.

Post #22,222,222 WAG contest:

For the first time in the history of this board, I am pleased to announce that IHUB has authorized a $222.22 CASH Sponsorship for the Post #22,222,222 WAG CONTEST!

The sponsor for this contest will be...

http://www.acmechart.com

A soon to be released Complete Microcap Trading Program!!!

PRIZES are as follows...

$100 for closest WAG
$25 for closest WAG before the winner
$25 for closest WAG after the winner
$50 to the member that actually posts Post #22,222,222 on IHUB.
BOOBY PRIZE!...$22.22 to the poster who WAGS 22 minutes and 22 seconds TOO LATE

ALL WAGS must be posted BEFORE post #22,100,000 appears on IHUB.

Read the IBOX for all other pertinent rules of this contest.

POST YOUR WAG NOW !!!!

And, THANKS ACMECHART.COM for sponsoring this contest!

http://www.investorshub.com/boards/board.asp?board_id=1594

whats the ticker?

are you sure about that? Just in pink land?

In normal circumstances, a vote or proxy would be held prior to the event.

However, the rules change when written in pink.

Good question on the notification timing, imho.........

Domer, you single handedly effected trading for thousands
of people. I find that crucial to the history of the stock market.

It's one of the many topics that could throw the entire jam
into another 3 day Fat Cat fest, imho.

Don't worry, I'll handle the bar on this one.

RE: Friday's Jam......we'll need to gather posts regarding the "glitch" and the timing of Domer when he screamed......
http://www.investorshub.com/boards/read_msg.asp?message_id=17455229

I'm laughing so hard....

It's entirely up to you. :)

per the ibox: Please, no spamming or wild pumping/bashing. Exclamation points: limit 3 in the headline; up to 12 may be used within the body of your post. You will be charged 1,000 shares of CMKX for each additional exclamation point. There is no limit on question marks, which are always encouraged :)

say it- don't spray it, Domer.

Awesome. Board: For review on Daisy/Donut plays:

Posted by: lady*b
In reply to: stevenktallman who wrote msg# 36149 Date:5/16/2007 9:09:53 PM
Post #of 44811

do you want a donut play or a daisy play?

A daisy play is speculation, and a touch of luck.

A donut play is when Serf and I bet a donut based on opposing
predictions.

JSDA Daisy Play for tomorrow, imho :)

JSDA AFTERHOURS: Jones Soda Gets Exclusive Rights to Natural Ingredient from Japan for Use in New Type of Energy Drink
Tuesday June 26, 9:30 pm ET


SEATTLE--(BUSINESS WIRE)--Jones Soda Co. (the "Company" or "Jones Soda"), today announced that it has entered into an agreement with Pharma Foods International Co., LTD., of Kyoto, Japan; Mitsubishi Corporation (MC), of Tokyo, Japan; and Mitsubishi International Food Ingredients, Inc. (MIFI), of Dublin, Ohio that grants the company exclusive rights to use PHARMA GABA(TM) in beverage applications.



PHARMA GABA(TM) is a naturally produced form of the amino acid gamma-aminobutyric acid (GABA), a key neurotransmitter in the human brain that exerts a number of anti-stress effects among other benefits. An extremely popular food ingredient in Japan, PHARMA GABA(TM) recently achieved GRAS (generally recognized as safe) status in the United States. According to Peter van Stolk, President and CEO, of Jones Soda, "Securing the rights to PHARMA GABA(TM) is the key step in our development of an entirely new type of Jones energy beverage." Rather than produce a stimulant effect like caffeine-containing energy beverages, PHARMA GABA(TM) is valued for its ability to promote mental focus. The current energy beverage category is estimated to be over $6 billion in sales annually and is expected to exceed $10 billion by 2010.

In Japan, the most popular applications of PHARMA GABA(TM) include use in coffee as it is particularly helpful in counteracting the negative effects of caffeine, as well as chocolate, sports beverages, water, energy beverages and candy. Noriko Iwaki, Executive Managing Director of Pharma Foods, expressed that, "Jones Soda is the perfect partner to introduce this new and exciting beverage concept to North America." With a history of bold innovation and marketing, Jones Soda will be assisted in the development of the new energy beverage by Dr. Michael T. Murray, one of the world's leading authorities on natural food products. An author of over 30 books on health and nutrition, Dr. Murray has played a major role in building the nearly $20 billion a year natural food and supplement industry as he has been instrumental in bringing many natural and effective food products to prominence in North America including glucosamine sulfate and Ginkgo biloba extract. According to Dr. Murray, "PHARMA GABA(TM) is poised to become a major dietary supplement and food ingredient in the North America because it produces such noticeable effects."

Peter van Stolk adds, "We are extremely excited to be working with Dr. Murray, Pharma Foods, and MC/MIFI in developing a truly unique beverage that can help give people what they really want - a natural energy product without the adverse effects of caffeine. At the same time, we are creating new growth vehicles for the future as we look to capture additional market share and return increased value to our shareholders."

The new product line is expected to be available at select retail locations by winter 2007.

About Jones Soda Co.

Headquartered in Seattle, Washington, Jones Soda Co., sells its Jones Soda products through its distribution network in select markets across North America. A leader in the premium soda category, Jones is known for its innovative labeling technique that incorporates always-changing photos sent in from its consumers. Jones Soda is sold through traditional beverage retailers and everywhere you'd never expect to find a soda.

This press release contains forward-looking statements and projections concerning the Company's plans, strategies, expectations, predictions and financial projections concerning the Company's future activities and results of operations and other future events or conditions, and are "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Words such as "expect," "believe," "anticipate," "may," "will," "plan," "intend," "estimate," "could," and other similar expressions are intended to identify these forward-looking statements. In particular, statements in this release regarding potential growth opportunities, working capital and cash flow management, operational and expense controls, future profitability and results of operations are forward looking. Statements in this press release, and elsewhere, that look forward in time or include anything other than historical information involve risks and uncertainties that may affect the Company's actual results of operations. These statements by the Company are subject to certain risks, including, among others, future demand for its products, competition from other businesses providing similar products, the ability to maintain profitability and control expenses and the Company's ability to successfully execute its business strategy. These and other risks and uncertainties are discussed in more detail in the Company's periodic reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, which are available at the SEC website at www.sec.gov.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information herein.



Contact:
Jones Soda Co.
Peter van Stolk, 206-624-3357
pvs@jonessoda.com
or
Integrated Corporate Relations, Inc.
Chad Jacobs, 203-682-8200
chad.jacobs@icrinc.com

--------------------------------------------------------------------------------
Source: Jones Soda Co.

http://biz.yahoo.com/bw/070626/20070626006467.html?.v=1

SPEECH!!

THE NEW FAT CATS POSTER OF THE WEEK IS:

JMRSAGE1
http://www.investorshub.com/boards/profile.asp?User=72392

Jmrsage1,

Not ONLY were you nominated by two posters this week for
our new board title, you EARNED IT.

You have been helpful with your picks, DD and to-the-point posts.

Anyone who looks at your profile should mark you. They will
see 787 fantastic posts about trading and investing.

For somebody who has not even posted 1000 times over the
course of your year with IHUB, it's no wonder you've got
membermarks. You know your stocks, and our board appreciates
your participation here.

THANK YOU for being one of our own Fat Cats!!

Afterhours PR: THIS is so informative:

This Is a Test From PR Newswire - 3
Tuesday June 26, 8:41 pm ET


WASHINGTON, June 26 /PRNewswire-USNewswire/ -- This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire.

ADVERTISEMENT


This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire.

This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire.

This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire.

This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire.

This Is a Test From PR Newswire

This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire.




--------------------------------------------------------------------------------
Source: PR Newswire Test

http://biz.yahoo.com/prnews/070626/dc01088.html?.v=1

NKE: AFTERHOURS: Nike Shares Jump 5.5% on Strong Q4 Earnings, Upside Orders/Guidance
http://biz.yahoo.com/seekingalpha/070626/39450_id.html?.v=1

53.82 +0.01 : Reports Q4 (May) earnings of $0.86 per share, in line with the Reuters Estimates consensus of $0.86; revenues rose 9.4% year/year to $4.38 bln vs the $4.36 bln consensus. The Company reported worldwide futures orders for athletic footwear and apparel, scheduled for delivery from June 2007 through November 2007, totaling $7.7 bln, 12% higher than such orders reported for the same period last year.

CPII: AFTERHOURS: 19.95 CPI Receives Prestigious Contract to Complete Development of 94 GHz Extended Interaction Klystron for EarthCARE Cloud-Profiling Radar
Tuesday June 26, 4:30 pm ET
NASA honors CPI employees with two Public Service Group Achievement Awards for their work on similar technology for NASA's CloudSat radar

Shares Outstanding: 16.31M
Float: 7.16M

PALO ALTO, Calif., June 26 /PRNewswire-FirstCall/ -- Communications & Power Industries, Inc. (CPI), a leading provider of microwave, radio frequency, power and control solutions for critical defense, communications, medical, scientific and other applications, has been awarded a $1.8 million follow-on contract from Japan's National Institute of Information and Communications Technology (NICT) to fund the design modifications and production of a 94 gigahertz Extended Interaction Klystron (EIK) for the Earth, Clouds Aerosols and Radiation Explorer (EarthCARE) mission cloud- profiling radar. CPI expects to receive future contracts of approximately $4 million over the next several years to meet ongoing program requirements for the EarthCARE mission. CPI's EIK, which will be submitted for the space qualification program for EarthCARE, will act as the enabling technology for the satellite-installed EarthCARE radar. CPI is a subsidiary of CPI International, Inc. (Nasdaq: CPII - News).


(Logo: http://www.newscom.com/cgi-bin/prnh/20060426/CPILOGO)

The EarthCARE space mission, an Earth Explorer Core mission of the European Space Agency's (ESA's) Living Planet Programme, is an advanced joint mission between the ESA, the Japan Aerospace Exploration Agency (JAXA) and NICT to address the need for better comprehension of the interaction between the aerosol, cloud and radiative processes that play a role in climate regulation. By acquiring vertical profiles of aerosols, clouds and radiant energy at the top of the atmosphere, as well as the vertical velocity of clouds, the EarthCARE mission is intended to improve the physical representation and parameters of those atmospheric phenomena in climate and numerical weather forecast models. In addition to the advanced cloud-profiling radar, EarthCARE will carry a laser radar operating with ultraviolet light, a cloud-imaging, multi-spectral camera and a sensor to measure radiated energy from Earth to outer space. The satellite launch is planned for 2013.

"Scientists' current ability to observe the global properties of aerosols, clouds and their associated processes is fairly limited, resulting in the creation of inconsistent model projections for future climate changes, such as those that may be brought about by global warming," said Joe Caldarelli, chief executive officer of CPI. "Using CPI's high-power EIK to enable the cloud-profiling radar, the EarthCARE mission can collect more complete climate information, making possible more accurate climate change models and predictions. For the past six years, CPI has been working with several international space agencies to develop the technology necessary for this vital program, and we look forward to continuing to work on the EarthCARE mission."

CPI's 94 gigahertz EIK is the key enabling technology for cloud-profiling radars. Previously, CPI provided a space-qualified 94 gigahertz EIK for the cloud-profiling radar on-board NASA's CloudSat, an Earth Observation satellite that was launched in April 2006. Since being launched into orbit more than a year ago, CloudSat has made more than 5,300 orbits around the Earth, taken more than 160 million vertical profiles of clouds and distributed more than six terabytes of data to the international science community. For both the CloudSat and EarthCARE missions, CPI's EIK amplifies low-power radar signals and converts them to high-power radar pulses, which are transmitted into the Earth's atmosphere by the cloud-profiling radar. EarthCARE's radar will be more than six to eight times more sensitive than that of CloudSat. In May, more than 120 scientists and engineers from Canada, Europe, Japan, the United States and China gathered at European Space Research and technology Center (ESTEC) in Noordwijk, the Netherlands to debate scientific issues for the preparation of the EarthCARE mission.

Recently, several CPI employees were selected by NASA as recipients of the 2007 NASA Honor Awards in recognition for their work on the 94 gigahertz EIK used on the cloud-profiling radar on CloudSat. In a ceremony later this summer, David Berry, Albert Roitman, Edward Sokol and Brian Steer will receive two NASA Public Service Group Achievement Awards "for successful delivery and on-orbit checkout of the first spaceborne 94 gigahertz cloud-profiling radar" and "for the successful development of the first space-qualified 94 gigahertz EIK and the high-power, high-voltage power supply" on-board CloudSat. The NASA Public Service Group Achievement Award is given to a group of non-government personnel for "an outstanding accomplishment while participating in a significant program or project that has contributed substantially to the NASA mission."

"We are very proud of the innovative work that our EIK team has done on the CloudSat and EarthCARE radars, and I want to congratulate them on winning these prestigious awards from our partners at NASA," said Caldarelli.

Since 2001, under contracts from the ESA, NICT and the Canadian Space Agency (CSA), CPI has been working with these agencies to develop a space-qualified, 94 gigahertz EIK that will meet a three-year operational requirement for the EarthCARE cloud-profiling radar. CPI is the only company to produce the high-power, 94 gigahertz EIK. During the next several years, CPI expects to receive future contracts from these agencies to fund the qualification and acceptance programs and the development of flight model EIKs for spacecraft integration.

CPI pioneered and developed EIK technology at its Canadian facility and has sold more than 1,000 commercial EIKs for use in millimeter wave radar, communications systems and scientific applications.

About CPI International, Inc.

CPI International, Inc., headquartered in Palo Alto, California, is the parent company of Communications & Power Industries, Inc., a leading provider of microwave, radio frequency, power and control solutions for critical defense, communications, medical, scientific and other applications. Communications & Power Industries, Inc. develops, manufactures and distributes products used to generate, amplify and transmit high-power/high-frequency microwave and radio frequency signals and/or provide power and control for various applications. End-use applications of these systems include the transmission of radar signals for navigation and location; transmission of deception signals for electronic countermeasures; transmission and amplification of voice, data and video signals for broadcasting, Internet and other types of communications; providing power and control for medical diagnostic imaging; and generating microwave energy for radiation therapy in the treatment of cancer and for various industrial and scientific applications.

Certain statements included above constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements provide our current expectations, beliefs or forecasts of future events. Forward-looking statements are subject to known and unknown risks and uncertainties, which could cause actual events or results to differ materially from the results projected, expected or implied by these forward looking statements. These factors include, but are not limited to, competition in our end markets; our significant amount of debt; changes or reductions in the U.S. defense budget; U.S. government contracts laws and regulations; changes in technology; the impact of unexpected costs; inability to obtain raw materials and components; and currency fluctuations. These and other risks are described in more detail in our periodic filings with the Securities and Exchange Commission. As a result of these uncertainties, you should not place undue reliance on these forward-looking statements. All future written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. We undertake no duty or obligation to publicly revise any forward-looking statement to reflect circumstances or events occurring after the date hereof or to reflect the occurrence of unanticipated events or changes in our expectations.




--------------------------------------------------------------------------------
Source: Communications & Power Industries, Inc.
http://biz.yahoo.com/prnews/070626/aqtu155.html?.v=8

Posted by: landm19
In reply to: None Date:6/26/2007 6:27:00 AM
Post #of 115005

VCLK YHOO Oppenheimer transitions coverage of ValueClick (VCLK 28.66) with a Buy and a $36 tgt... Oppenheimer transitions coverage of Yahoo (YHOO 27.64) with a Buy and a $34 tgt.

http://www.investorshub.com/boards/read_msg.asp?message_id=20745720

RMKR 6.77 Rainmaker Awarded Multi-Year Contract With Global Notebook Computer Manufacturer
Tuesday June 26, 6:30 am ET
Company Selected to Provide Lead Generation and Marketing Support Services for All of North America


CAMPBELL, Calif., June 26 /PRNewswire-FirstCall/ -- Rainmaker Systems, Inc. (Nasdaq: RMKR - News), a leading provider of sales and marketing solutions combining hosted application software and execution services, today announced that a leading global notebook computer manufacturer has selected Rainmaker to provide lead generation, telesales, and marketing support services for the company's North American operations.


The multi-year agreement extending into 2010 calls for Rainmaker to provide hosted, on-demand applications and integrated marketing services to assist the Client with outbound lead generation, lead management and nurturing; list development and distribution; inbound call, email and chat support; special projects including outbound email and direct response campaign implementation and management; and customer-care program services.

LeadWorks(TM), Rainmaker's proprietary, end-to-end Web-based solution that integrates lead generation and distribution management, campaign management, monitoring, recording and robust reporting capabilities, will be deployed across four of the Client's enterprise verticals comprised of numerous industry segments throughout North America.

Rainmaker will also deploy a branded Channel Partner Portal allowing the Client's resellers on-demand access to highly qualified sales leads and existing customer information.

"We look forward to deploying our unique, fully-integrated combination of hosted technology, data and expertise to help drive revenue for our Client and their channel partners," said Michael Silton, Rainmaker's CEO. "This was a very competitive bid process. We are delighted to have been awarded the contract and the opportunity that it provides to expand our relationship with them while helping to drive their strategic growth objectives."

About Rainmaker

Rainmaker Systems, Inc. delivers sales and marketing solutions, combining hosted application software and execution services designed to drive more revenue for our clients. Our Revenue Delivery PlatformSM combines proprietary, on-demand application software and advanced analytics with specialized sales and marketing execution services. Rainmaker clients include large enterprises in a range of industries, including computer hardware and software, telecommunications, and financial services industries. For more information visit http://www.rmkr.com or call 800-631-1545.

NOTE: Rainmaker Systems, the Rainmaker logo, Sunset Direct and Contract Renewals Plus are registered with the U.S. Patent and Trademark Office. All other service marks or trademarks are the property of their respective owners.

This press release contains forward-looking statements regarding future events. These forward-looking statements are based on information available to Rainmaker as of this date and they assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance, and actual results could differ materially from current expectations. Among the important factors which could cause actual results to differ materially from those in the forward-looking statements are general market conditions, unfavorable economic conditions, our ability to execute our business strategy, our ability to integrate acquisitions without disruption to our business, the effectiveness of our sales team and approach, our ability to target, analyze and forecast the revenue to be derived from a client and the costs associated with providing services to that client, the date during the course of a calendar year that a new client is acquired, the length of the integration cycle for new clients and the timing of revenues and costs associated therewith, our client concentration given that we are currently dependent on a few significant client relationships, potential competition in the marketplace, the ability to retain and attract employees, market acceptance of our service programs and pricing options, our ability to maintain our existing technology platform and to deploy new technology, our ability to sign new clients and control expenses, the possibility of the discontinuation and/or realignment of some client relationships, and the financial condition of our clients' businesses, and other factors detailed in the Company's filings with the Securities and Exchange Commission, including our filings on Forms 10-K and 10-Q.




--------------------------------------------------------------------------------
Source: Rainmaker Systems, Inc.

http://biz.yahoo.com/prnews/070626/latu085.html?.v=101

Ug

as in "ADDING HERE" ?

HMIN: AFTERHOURS: 32.07
Home Inns to Acquire the Remaining Minority Stake in Home Inns Beijing And All of the Equity Interest in Beijing City Sunshine Hotels Management
Monday June 25, 8:36 pm ET


SHANGHAI, China, June 25 /Xinhua-PRNewswire/ -- Home Inns & Hotels Management Inc. announced today that it has entered into a definitive agreement to acquire the remaining 4.412% stake in its majority owned subsidiary, Home Inns & Hotels Management (Beijing) Ltd. ("Home Inns Beijing"), and another definitive agreement to acquire Beijing City Sunshine Hotel Management Inc ("Beijing City Sunshine"), a hotel management company with three leased-and-operated hotels in Beijing.


Acquisition of the Remaining 4.412% Stake in Home Inns Beijing

Home Inns currently owns 95.588% of Home Inns Beijing, the subsidiary that operates all Home Inns' leased-and-operated hotels, while the remaining 4.412% is owned by a joint venture partner which is a subsidiary of Beijing Tourism Group. Upon acquisition of the remaining 4.412% stake, Home Inns Beijing will become a wholly-owned subsidiary of Home Inns. Home Inns has agreed to pay a total consideration consisting of RMB 60 million and 441,661 ordinary shares of Home Inns. This transaction is expected to close in the third quarter of 2007. Home Inns Beijing generated revenue of RMB 567.9 million and RMB174.6 million in 2006 and the first quarter of 2007, respectively, which contributed to approximately 96.5% and 95.4% of Home Inns' total revenues in 2006 and the first quarter of 2007, respectively.

"After the acquisition, we will own all of the economic interest in Home Inns Beijing, and eliminate the portion of the minority interest in our income statement currently attributed to this 4.412% stake in Home Inns Beijing," said Ms. May Wu, Home Inns' Chief Financial Officer, "In addition, it is a strategically important move for Home Inns as the new and simplified corporate structure may allow us to substantially shorten the capital injection and currency conversion cycle at Home Inns Beijing, which in turn will better serve our rapid expansion activities."

Acquisition of Beijing City Sunshine Hotel Management Inc.

Beijing City Sunshine has two leased-and-operated economy hotels in operation and one additional hotel under development in Beijing. Home Inns will acquire Beijing City Sunshine in its entirety, for an undisclosed amount of cash. This acquisition is expected to close in early third quarter and is expected to add approximately RMB 6 million in revenues for the remainder of 2007.

"We are very pleased to bring into our portfolio these three additional hotels with excellent locations in Beijing," said David Sun, Home Inns' Chief Executive Officer. "We are even more excited about converting these properties into Home Inns hotels and achieving Home Inns' performance at these hotels in the foreseeable future."

About Home Inns

Home Inns is a leading economy hotel chain in China based on the number of hotels and hotel rooms, as well as the geographic coverage of the hotel chain. Since Home Inns commenced operations in 2002, it has become one of the best- known economy hotel brands in China. Home Inns offers a consistent product and high-quality services to primarily serve the fast growing population of value- conscious individual business and leisure travelers who demand clean, comfortable and convenient lodging. Home Inns' ADSs, each of which represents two ordinary shares, are currently trading on the NASDAQ Global Market under the symbol "HMIN." For more information about Home Inns, please visit http://english.homeinns.com .

Safe Harbor

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the outlook for the remainder of 2007 and quotations from management in this announcement, as well as Home Inns' strategic and operational plans, contain forward-looking statements. Home Inns may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to first parties. Statements that are not historical facts, including statements about Home Inns' beliefs and expectations, are forward-looking statements. Forward- looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: our anticipated growth strategies; our future business development, results of operations and financial condition; expected changes in our revenues and certain cost or expense items; our ability to attract customers and leverage our brand; trends and competition in the lodging industry; our ability to hire, train and retain qualified managerial and other employees; our ability to develop new hotels at desirable locations in a timely and cost-effective manner; the expected growth of the Chinese economy hotel market; and Chinese governmental policies relating to private managers and operators of hotels and applicable tax rates.

Further information regarding these and other risks is included in our registration statements on Form F-1 and other documents filed with the SEC. Home Inns does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of June 26, 2007, and Home Inns undertakes no duty to update such information, except as required under applicable law.


For investor and media inquiries, please contact:

Angela Li
Home Inns & Hotels Management Inc.
Tel: +86-21-32189988, ext. 2004
Email: xlli@homeinns.com




--------------------------------------------------------------------------------
Source: Home Inns & Hotels Management Inc.
http://biz.yahoo.com/prnews/070625/cnm025.html?.v=4

PHIL: Nice addition to the mods here. Smokintek is fantastic with landscaping
and has been giving me lots of great ideas and tips since the early spring.
He even gave me a new lucky daisy! (below)

:)

GLTY,
Me

BX: I have no huge concerns at this point. I stand by my thoughts from last week, fwiw.
IPO's are very very volatile
out of the gate- the waters should calm soon, imho. :)

Blackstone Sinks in Second Trading Day
Monday June 25, 4:13 pm ET
By Dan Seymour, AP Business Writer
Shares of Blackstone Group Drop As Investors Struggle With Valuation


NEW YORK (AP) -- Shares of Blackstone Group LP sank during their second day of trading Monday, as the stock pulled back sharply following a widely hyped initial public offering.
The stock fell 7.5 percent, or $2.62, to close at $32.44. It was among the loss leaders on a percentage basis on the New York Stock Exchange, having fallen as low as $31.90 on volume of more than 35 million shares.


The decline also wiped nearly $600 million off the personal fortune of Stephen Schwarzman, the company's chief executive and largest shareholder.

Nick Perry, an equity options analyst at Schaffer's Investment Research, said a pullback the second trading day after a high-profile IPO is typical.

"There was a whole lot of attention on this deal, and weakness usually follows when a stock has been hyped as much as Blackstone was," he said. "That usually goes away after a day or two."

Shares of Blackstone jumped 13.1 percent on Friday after the private equity firm fetched $31 per share in its IPO. It was the largest U.S. IPO in five years and the sixth-largest ever.

But valuing Blackstone Group is a tricky proposition. Normally investors measure a company against the worth of similar companies. But Fortress Investment Group is the only stock comparable to Blackstone Group, and even then, Fortress operates certain funds that do not correlate to Blackstone.

Plus, Blackstone faces the possibility of a sharp tax hike under proposed legislation in Congress. Depending on what version is approved, this tax hike could take effect either immediately or in five years, further heightening the uncertainty investors face when trying to determine how much Blackstone is worth.

Barron's, the investment magazine published by Dow Jones, ran a cover story on Blackstone in its new issue arguing the firm's stock may disappoint investors.

Blackstone's IPO may hint at the top of the private equity boom, Barron's contended, as the firm seeks to cash in on its business before rising interest rates and expensive stocks hamper the industry.

The stock price assumes Blackstone will be able to keep turning public companies around and selling them for a profit, Barron's said. Based on the obstacles facing this assumption, Barron's argued Blackstone's stock is significantly overvalued.

Earlier this year, Fortress Investment Group LLC became the first publicly traded hedge fund to go public. The stock priced at $18.50 in its IPO and spiked by more than two-thirds to close its first day of trading at $31. The shares subsequently cooled off, falling about 10 percent in the next week. The shares fell 4.1 percent to $23.25 Monday.

AP Business Writers Joe Bel Bruno and Kristen A. Lee in New York contributed to this report.

http://biz.yahoo.com/ap/070625/blackstone_group_mover.html?.v=3

AFOP: AFOP Raises 2nd Quarter, 2007 Guidance
Monday June 25, 7:30 am ET


SUNNYVALE, Calif.--(BUSINESS WIRE)--Alliance Fiber Optic Products, Inc. (NASDAQ:AFOP - News), an innovative supplier of fiber optic components, subsystems and integrated modules for the optical network equipment market, today announced that it will raise its revenue guidance for the quarter ended June 30, 2007.


For the 2nd quarter of 2007, the Company expects to report net sales above $8.3 million, exceeding previously stated revenue guidance provided in the first quarter conference call. This revenue level represents approximately 34% growth compared with the year ago quarter. The Company's higher than anticipated net sales in the second quarter of 2007 primarily reflects stronger than expected demand from customers.

Detailed financial results for the second quarter as well as the outlook for the third quarter of 2007 will be provided, when complete second quarter end results are announced on a conference call to be held in the week of July 23, 2007.

In addition to the guidance update, AFOP is pleased to announce the signing of Hakuto Co, Ltd. as our new representation partner for Japan. Hakuto has a long established and esteemed presence with Japanese technology customers and will offer AFOP improved capabilities to sell our innovative products in the Japanese market.

About AFOP

Founded in 1995, Alliance Fiber Optic Products, Inc. designs, manufactures and markets a broad range of high performance fiber optic components and integrated modules. AFOP's products are used by leading and emerging communications equipment manufacturers to deliver optical networking systems to the long-haul, enterprise, metropolitan and last mile access segments of the communications network. AFOP offers a broad product line of passive optical components including interconnect systems, couplers and splitters, thin film DWDM components and modules, fixed and variable optical attenuators, and depolarizers. AFOP is headquartered in Sunnyvale, California, with manufacturing and product development capabilities in the United States, Taiwan and China. AFOP's website is located at http://www.afop.com.

Except for the historical information contained herein, the matters set forth in this press release, including statements as to our future prospects, our beliefs regarding factors contributing to quarterly results, our ability to control expenses, our ability to improve operational efficiencies, our order trends and customer activity, and expected revenue growth and increased net profits, are forward looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including, but not limited to general economic conditions and trends, the impact of competitive products and pricing, timely introduction of new technologies, timely design acceptance by our customers, the acceptance of new products and technologies by our customers, customer demand, the timing of customer orders, loss of key customers, ability to ramp new products into volume production, industry-wide shifts in supply and demand for optical components and modules, industry overcapacity, failure of cost control initiatives, financial stability in foreign markets, and other risks detailed from time to time in our SEC reports, including AFOP's Form 10-Q for the quarter ended March 31, 2007. These forward-looking statements speak only as of the date hereof. AFOP disclaims any intention or obligation to update or revise any forward-looking statements.



Contact:
Alliance Fiber Optic Products, Inc.
Anita Ho, 408-736-6900 x168
Acting Chief Financial Officer

--------------------------------------------------------------------------------
Source: Alliance Fiber Optic Products, Inc.

http://biz.yahoo.com/bw/070625/20070625005020.html?.v=1

GM PnP! :)

ADL 3.90 AMEX: AMDL Signs Additional New Two Year Chinese Distribution Agreement for Minimum Sales of Approximately $921,000
Monday June 25, 8:51 am ET

Shares Outstanding: 11.88M
Float: 11.75M

TUSTIN, Calif., June 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL - News), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi and Jilin China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (JPI), is an international biopharma company that engages in the development, manufacture and marketing of proprietary pharmaceutical and diagnostic products. AMDL announced today that through its subsidiary, JJB, it has signed an agreement with YunNan KunMing YuSi Pharmaceutical Co. Ltd. (YKY) to distribute levofloxacin (100ml/bottle). This $921,000 distribution agreement will be effective in July 2007 for a term of two years. YKY is a direct affiliate to the Commission of Science Technology and Industry for National Defense.

Mr. Frank Zheng, Managing Director of JPI, stated that "this additional purchase orders puts JPI on its way to building sales in China by as much as $24 million over the next 12 month sales cycle."

Mr. Gary Dreher, CEO of AMDL, noted that "this additional purchase agreement is truly exciting and significantly enhances JPI's ability to grow its sales in the China markets."

About Jade: Jade has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiary, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

About AMDL: More information about AMDL and its products can be obtained at http://www.amdl.com.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.


Contact: AMDL, Inc.
Mr. Paul Knopick
AMDL Investor Relations
Direct Line: 949.707.5365
Voice Mail: 714.505.4460




--------------------------------------------------------------------------------
Source: AMDL, Inc.
http://biz.yahoo.com/prnews/070625/lam078.html?.v=90

BX: Posted by: downtimepg
In reply to: None Date:6/25/2007 8:09:11 AM
Post #of 114743

interesting twist, bx

Republicans Say Democrats Interfered With Blackstone IPO
Last update: 6/25/2007 7:30:00 AM


By Siobhan Hughes
Of DOW JONES NEWSWIRES


(This article was originally published Friday.)
WASHINGTON (Dow Jones)--Republicans on the House Oversight and Government Reform Committee are accusing Democratic colleagues of engaging in "raw political interference" in a high-profile stock sale by Blackstone Group (BX).
Rep. Tom Davis, the Virginia Republican who is the ranking member on the panel, and Rep. Darrell Issa, the California Republican who leads an oversight subcommittee, say Democratic leaders applied political pressure by asking the Securities and Exchange Commission to delay allowing the offering to proceed.
Blackstone shares began trading Friday on the New York Stock Exchange one day after the SEC declared the investment firm's registration statement effective. House Oversight and Government Reform Committee Chairman Henry Waxman, a California Democrat, and his colleague Rep. Dennis Kucinich, an Ohio Democrat, had appealed to the SEC to slow the sale. They said Congress needed time to study the issue, citing concerns about whether an investment in Blackstone would give ordinary investors access to hedge funds and private-equity funds that may not be suitable.
"The Waxman/Kucinich request is an unwarranted interference in capital markets, which if successful will have a chilling effect on those markets," Davis and Issa wrote on June 22 to SEC Chairman Christopher Cox. "Their behavior attacks the very underpinnings of the American economy by exerting political interference in the rights of American entrepreneurs to raise money from the public."
Natalie Laber, a spokesperson for Kucinich, called the letter "a perfect example of the pot calling the kettle black. They are charging us with engaging in raw political interference - which we're not - yet they are telling the SEC what to do.
"Our comment to the SEC was on the process - which is within our rights - to ask them to slow down the process so that we can hold congressional hearings. We were not telling the agency how to determine a case."
Blackstone manages about $88 billion, with more than half in private-equity funds and hedge fund-related investments. Hedge funds and private-equity funds are little-regulated investment vehicles aimed at wealthy investors on the assumption that the affluent are better able to manage the risks associated with such investments. Under current SEC policy, an individual investor must have $1 million in net worth - including the value of a home - before investing in a hedge fund, although regulators have proposed raising that hurdle.
"The value of public investors' interests in Blackstone LP would be tied to the performance of the underlying hedge and private-equity funds, which have not been considered suitable investments for the general public because of their high risks and speculative nature," Waxman and Kucinich wrote. "While exposing unsophisticated investors to new risks, the Blackstone LP IPO would also apparently deprive them of control over the management of the funds and of many of the protections provided by fiduciary duties typically owed to them by management."
Blackstone has been drawing outsized attention from Congress amid broader scrutiny of private-equity funds and hedge funds. The Senate Finance Committee has already introduced legislation that would bar publicly traded partnerships that derive income from asset management services from qualifying for lower tax rates. Besides the letter from Waxman and Kucinich, Sen. James Webb, a Virginia Democrat, has raised national security concerns, citing Blackstone's holdings in satellite technology companies and firms that provide software and applications for use by the U.S. military.
The Chinese government purchased a $3 billion stake in Blackstone, and Webb wrote the SEC, the Treasury secretary, and the Homeland Security secretary on Friday that he was "disappointed to learn that the public offering has gone forward, without an indication that you have addressed the serious national security concerns inherent in the government of China's $3 billion investment, since the Blackstone Group owns companies that provide software and applications for use by the military and in satellite technology."
SEC spokesman John Nester declined to comment.
The SEC is an independent agency that reviews stock-offering documents before the offerings are allowed to proceed. Nester on Thursday noted that the agency may only refrain from declaring a statement effective in the case of "material misstatements or omissions." He also pointed to the protections offered by existing securities laws, "which the commission has rigorously applied."
http://www.investorshub.com/boards/read_msg.asp?message_id=20715121

TIXC.OB 5.90 Tix Corporation Announces New Record Gross Ticket Sales for May 2007
Monday June 25, 8:00 am ET


STUDIO CITY, Calif., June 25 /PRNewswire-FirstCall/ -- TIX CORPORATION (OTC Bulletin Board: TIXC - News; the "Company") is pleased to announce that its Las Vegas half-price, same-day ticket business, Tix4Tonight, along with its newest acquisition, AnyEvent.com, reported a new record for monthly gross ticket sales. May 2007 gross ticket sales were $3,550,502 up 98% over May 2006 gross ticket sales of $1,793,893. The gross ticket sales from Tix4AnyEvent.com, which accounted for over $1 million of the total gross ticket sales, were booked during the month of May, but will not be recognized in full until the date of each event for which it sold tickets.
ADVERTISEMENT


Tix Corporation's wholly-owned subsidiary, Tix4Tonight, sells tickets for Las Vegas shows, concerts, attractions and sporting events at half-price, on the same day of the performance. The Company also offers two additional discount products at its Las Vegas facilities, Tix4Golf and Tix4Dinners. Tix4Golf offers discount golf tee times for over 35 courses in Las Vegas for both same-day and advanced bookings and Tix4Dinners offers up to 50% off entrees at local Las Vegas restaurants and buffets. The Company's recent acquisition, AnyEvent.com, sells premium tickets to concerts, theater and sporting events throughout the country.

Tix4Tonight has four prime ticket booth facilities, strategically placed at highly foot-trafficked locations in Las Vegas, Nevada. They include: the Hawaiian Marketplace at the South end of the Strip; the Fashion Show Mall in front of Neiman Marcus, directly across the street from the new Wynn Resort at the middle of the Strip; at the North Strip, just South of the Riviera Hotel; and a downtown Las Vegas facility in the Four Queens Hotel, fronting onto the Fremont Street Experience.

For more information and answers to typical questions about how the Tix4Tonight service works, call 877-849-4868 or visit www.tix4tonight.com.

Cautionary Statement pursuant to Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:

All statements in this news release that are not statements of historical fact are deemed to be forward-looking statements. These forward-looking statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward- looking statements. Many of these risks and uncertainties are identified in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements. This document is only for the general information of shareholders, potential investors and other interested parties, and is not to be construed as an offer to sell or the solicitation of an offer to buy any securities. The opinions expressed herein are the current opinions of management as of the date appearing on this document.



http://biz.yahoo.com/prnews/070625/clm038.html?.v=85
--------------------------------------------------------------------------------
Source: TIX CORPORATION

Multi-task-same-salary launch pad

SLW: 11.70 NYSE: Silver Wheaton Announces 50% Increase in Proven and Probable Silver Reserves at Penasquito Project
Monday June 25, 7:35 am ET


VANCOUVER, BRITISH COLUMBIA--(MARKET WIRE)--Jun 25, 2007 -- Silver Wheaton Corp. ("Silver Wheaton") (Toronto:SLW.TO - News)(NYSE:SLW - News) is pleased to announce that Goldcorp Inc. ("Goldcorp") has released updated reserves and resources for their Penasquito Project located in Zacatecas, Mexico. Proven and probable silver reserves have increased by 50% to 864 million ounces, while measured and indicated silver resources, exclusive of reserves, have increased by 67% to 413 million ounces. The calculation is based on assays from an additional 240 drill holes (including condemnation drill holes) completed since the previous reserve update in June, 2006.


Silver Wheaton will receive 25% of the life of mine silver production from Goldcorp's Penasquito Project. The attributable silver reserves and resources to Silver Wheaton from the Penasquito Project are outlined in the following table:



Penasquito Project Reserves and Resources
FULL READ
http://biz.yahoo.com/iw/070625/0270411.html

Domer, I just read that PR twice in my morning fog. Actually,
the concept is pretty innovative, imho. I'm sure an efficiency expert is jumping and smiling on that technology.

GPCB - 26.33 GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
Monday June 25, 2:36 am ET
- Deal includes $10 million upfront payment
- Yakult responsible for all development, marketing and sales costs for Japan


MARTINSRIED/MUNICH, Germany /PRNewswire-FirstCall/ -- GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index; Nasdaq: GPCB) today announced that the Company has entered into a license agreement with Yakult Honsha Co. Ltd. for satraplatin in Japan.
ADVERTISEMENT


Under the terms of the agreement, Yakult gains exclusive commercialization rights to satraplatin for Japan and will take the lead in developing the drug in Japan. Yakult is to provide an upfront payment of 1.2 billion yen (~$10 million) to GPC Biotech as reimbursement for past satraplatin clinical development expenses. Yakult will also make GPC Biotech additional payments based on the achievement of certain regulatory filing and approval milestones. GPC Biotech will also receive a minimum of 21% royalties on sales of satraplatin in Japan.

Bernd R. Seizinger, M.D., Ph.D., Chief Executive Officer of GPC Biotech, said: "We are delighted to have Yakult as our partner for Japan. Yakult's pharmaceutical business specializes in cancer and cancer-related ailments and has expanded its operations in this area. They are the inventor of irinotecan, which is a global standard drug for colorectal cancer, and have a solid track record of successfully commercializing another platinum-based drug, oxaliplatin, in Japan. They also share the development philosophy of GPC Biotech and plan to develop satraplatin for additional cancer indications for Japan. We look forward to a productive working relationship with Yakult."

Teruo Yokokura, Ph.D., Head of Pharmaceutical Division of Yakult Honsha Co., Ltd., said: "We are excited to have the opportunity to develop and commercialize satraplatin for the Japanese market. We look forward to building on the solid foundation of the Phase 3 data from the satraplatin SPARC trial conducted by GPC Biotech in second-line hormone-refractory prostate cancer to bring this product through development, the regulatory process and onto the market in Japan. We believe that, if shown to be effective and well-tolerated, satraplatin, which is given as capsules that patients can take at home, could be an important option for cancer patients in Japan."

About Satraplatin

Satraplatin, an investigational drug, is a member of the platinum family of compounds. Platinum-based drugs are a critical part of modern chemotherapy treatments and are used to treat a wide variety of cancers. All platinum drugs currently on the market require intravenous administration. Satraplatin is an oral compound that clinical trial patients are able to take at home. Satraplatin is not currently approved by the FDA in the United States, by the EMEA in the European Union or any other regulatory authority and no conclusions can or should be drawn regarding its safety and efficacy.

A Phase 3 registrational trial, called SPARC, is evaluating satraplatin plus prednisone versus placebo plus prednisone in 950 patients with hormone- refractory prostate cancer whose prior chemotherapy has failed. Data from the trial showing a statistically significant improvement in progression-free survival and data on prostate specific antigen (PSA) have been presented at recent medical conferences. The satraplatin NDA, filed on February 15 2007, is currently under review by the U.S. FDA for hormone-refractory prostate cancer patients whose prior chemotherapy has failed and will be reviewed by the Oncologic Drugs Advisory Committee (ODAC) on July 24, 2007. The FDA has accepted for filing the Company's NDA and granted the NDA priority review status. An action from the FDA on the application is expected in August of this year.

GPC Biotech has a co-development and license agreement with Pharmion GmbH, a wholly owned subsidiary of Pharmion Corporation, under which Pharmion has been granted exclusive commercialization rights to satraplatin for Europe and certain other territories. Pharmion has indicated it expects to complete the Marketing Authorization Application (MAA) for satraplatin for Europe in the second quarter of 2007. GPC Biotech in-licensed satraplatin from Spectrum Pharmaceuticals, Inc. in 2002.

Satraplatin has been studied in clinical trials involving a range of tumors. Trials evaluating the effects of satraplatin in combination with radiation therapy, in combination with other cancer therapies and in a number of cancer types are underway or planned.

About GPC Biotech

GPC Biotech AG is a publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs. GPC Biotech's lead product candidate satraplatin is currently under review by the U.S. FDA for hormone-refractory prostate cancer patients whose prior chemotherapy has failed. GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors. GPC Biotech AG is headquartered in Martinsried/Munich (Germany), and has a wholly owned U.S. subsidiary headquartered in Princeton, New Jersey. For additional information, please visit GPC Biotech's Web site at www.gpc-biotech.com.

This press release contains forward-looking statements, which express the current beliefs and expectations of the management of GPC Biotech AG, including statements relating to results of the SPARC trial and statements relating to the potential efficacy and safety profile of satraplatin. Such statements are based on current expectations and are subject to risks and uncertainties, many of which are beyond our control, that could cause future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially depending on a number of factors, and we caution investors not to place undue reliance on the forward- looking statements contained in this press release. In particular, there can be no guarantee that additional information relating to the safety, efficacy or tolerability of satraplatin may be discovered upon further analysis of data from the SPARC trial or analysis of additional data from other ongoing clinical trials for satraplatin. Furthermore, we cannot guarantee that satraplatin will be approved for marketing in a timely manner, if at all, by regulatory authorities nor that, if marketed, satraplatin will be a successful commercial product. We direct you to GPC Biotech's Annual Report on Form 20-F for the fiscal year ended December 31, 2006 and other reports filed with the U.S. Securities and Exchange Commission for additional details on the important factors that may affect the future results, performance and achievements of GPC Biotech. Forward-looking statements speak only as of the date on which they are made and GPC Biotech undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future.




--------------------------------------------------------------------------------
Source: GPC Biotech

RE: DCBI- Do you think I have to own that pinkie to get in on the room block at MGM? lol!!

Anyone going to the DCBI.PK shareholders event in Vegas???

DC Brands Finalizes Room Block at MGM Grand
Friday June 22, 5:47 pm ET

http://biz.yahoo.com/iw/070622/0270166.html
Las Vegas Shareholder Event Expected to Draw Substantial Crowd


DENVER, CO--(MARKET WIRE)--Jun 22, 2007 -- DC Brands International's (Other OTC:DCBI.PK - News) President and CEO Richard Pearce and Director of Public Relations Aubrey Cornelius were in Las Vegas this week coordinating the details of the upcoming Las Vegas Shareholder Event to be held July 28, 2007, and finalized a room block at The MGM Grand. A limited number of rooms are available at a discounted rate for Friday and Saturday night (July 27 and 28) on a first come, first serve basis.
To book a room at the MGM Grand, call (800) 646-7787 and use either the group name "DC Brands Shareholder Event" or group code "DCI003." Due to MGM Grand's policy, DC Brands' room block is only held through July 9, so be sure to book as soon as possible to secure your space.

To RSVP for the shareholder meeting, send an email to vegasparty@dc-brands.com. Please note the deadline for RSVPs is July 12.

ADVERTISEMENT


While in Las Vegas, Pearce and Cornelius also met with The Palms for a site visit and are in discussions about adding an overflow space for the meeting and moving the reception to Rain, a larger nightclub within The Palms. This move is based on the overwhelming response from those that have pre-registered for the event.

"This week we shipped more than 4,800 newsletters containing a letter from myself and a formal invitation for the event," said Pearce. "If we already have more than 375 pre-registered attendees, I can't even imagine what the numbers will jump to once everyone receives their newsletter packages. We promise that the news we're prepared to share won't disappoint and we look forward to meeting many of our shareholders in person."

Following the trip to Las Vegas, Pearce flew to Los Angeles to help coordinate the Purrfect Angelz calendar shoot and hold several key meetings. Updates will be provided when he returns next week.

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.



Contact:
CONTACT:
Aubrey Cornelius
aubrey@sprocketcommunications.com
303.495.2883



--------------------------------------------------------------------------------
Source: DC Brands International, Inc.